跳至主要内容

First characterization of an anti-lipopolysaccharide factor (ALF) from hydrothermal vent shrimp: Insights into the immune function of deep-sea crustacean ALF

Author：Han-jie Gu, Qing-lei Sun, Shuai Jiang, Jian Zhang, Li Sun   《Developmental & Comparative Immunology》

ABSTRACTS
Anti-lipopolysaccharide factor (ALF) is a type of antimicrobial peptides (AMPs) with a vital role in antimicrobial defense. Although a large amount of ALFs have been identified from neritic and fresh water crustacean species, no functional investigation of ALFs from deep-sea animals have been documented. In the present study, we characterized the immune function of an ALF molecule (named RspALF1) from the shrimp Rimicaris sp. residing in the deep-sea hydrothermal vent in Desmos, Manus Basin. RspALF1 shares 51.5%–62.4% overall sequence identities with known shrimp ALFs and contains the conserved LPS binding domain (LBD). Both recombinant RspALF1 (rRspALF1) and the LBD-derived peptide (ALF1P1) bound to the cell wall components of Gram-negative and Gram-positive bacteria and killed a wide range of bacteria, especially those from deep-sea hydrothermal field, by damaging bacterial cellular structures. The bactericidal activities of rRspALF1 and ALF1P1 were optimal and stably maintained from 4?°C to 37?°C, which is comparable to the ambient temperature range of the habitat of Rimicaris sp. In addition to bacteria, rRspALF1 and ALF1P1 also exhibited anti-fungal activity. rRspALF1 and ALF1P1 exhibited high killing efficiencies, which, in terms of MIC values, were ranged between 0.25?μM and 4?μM for bacteria and 4?μM–8?μM for fungi. When introduced in vivo, both rRspALF1 and ALF1P1 effectively inhibited bacterial infection in shrimp and reduced the dissemination of bacterial and viral pathogens in fish. Together, these results provide the first insight into the biological property of deep-sea ALF and indicate that RspALF1 very likely plays a significant role in immune defense by functioning as a highly effective antimicrobial with a broad target range.
KEY WORDS
Anti-lipopolysaccharide factor; Antimicrobial peptides; Rimicaris sp.; Deep-sea hydrothermal vent; Antibacterial; Antiviral
SCREENSHOT

RELATED PRODUCTS
Peptides
CHAINING
https://www.sciencedirect.com/science/article/pii/S0145305X18300430
标签：

评论

发表评论

此博客中的热门博文

CAS:198483-36-2|Cholecystokinin Octapeptide (1-6) (desulfated)|DYMGWM

Contact： Liven Qian(钱叶华)-Custom Peptide Mobile: 13761298676（微信） Email：cps037@chinapeptides.net QQ：2880526724 ChinaPeptides Co., Ltd./强耀生物科技有限公司 Name Cholecystokinin Octapeptide (1-6) (desulfated) Code [198483-36-2] The alias Cholecystokinin Octapeptide (1-6) (desulfated) Sequence (single letter abbreviation) DYMGWM Sequence (three-letter abbreviation) Asp-Tyr-Met-Gly-Trp-Met A basic description solubility The molecular weight 801.94 Chemical formula C36H47N7O10S2 The purity 80%，90%，95%，98%，99% Weight 1mg,5mg,10mg,50mg,100mg,1g Storage conditions Store at -20°C. Keep tightly closed. Store in a cool dry place.
发表评论
阅读全文

Mitochondria Targeted Peptide Attenuates Mitochondrial Dysfunction, Controls Inflammation and Protects Against Spinal Cord Injury-Induced Lung Injury

文献作者：Zhu L.-L. · Li M.-Q. · He F. · Zhou S.-B. · Jiang W.     《Cellular Physiology and Biochemistry》 ABSTRACTS Background/Aims:   Spinal cord injury (SCI) is a common and devastating disease, which results in systemic inflammatory response syndrome and secondary lung injury. Mitochondrial dysfunction and inflammation are closely related to lung injury in diverse disease models. No studies have demonstrated the effects of mitochondrial targeted peptide SS-31 in a mouse model of SCI-induced lung injury.  Methods:   Immediately after injury, mice in the treatment groups received a daily, single-dose intraperitoneal injection of SS-31 and for the next 2 days. The sham and SCI groups also received a daily single dose of vehicle (DMSO and 0.9% NaCl, 1: 3). The lung tissue of mice was examined after SCI, and tissue damage, apoptosis, inflammation, and mitochondrial dysfunction were recorded.  Results:   SS-31 treatment attenuated lung edema ...
发表评论
阅读全文

CAS:83651-90-5|α-CGRP (mouse, rat)|SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2

Contact： Liven Qian(钱叶华)-Custom Peptide Mobile: 13761298676（微信） Email：cps037@chinapeptides.net QQ：2880526724 ChinaPeptides Co., Ltd./强耀生物科技有限公司 Name α-CGRP (mouse, rat) Code [83651-90-5] The alias α-CGRP (mouse, rat) Sequence (single letter abbreviation) SCNTATCVTHRLAGLLSRSGGVVK DNFV PTNVGSEAF-NH2 Sequence (three-letter abbreviation) Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 A basic description solubility The molecular weight Chemical formula The purity 80%，90%，95%，98%，99% Weight 1mg,5mg,10mg,50mg,100mg,1g Storage conditions Store at -20°C. Keep tightly closed. Store in a cool dry place. Number of Residues: 37 1-Letter Code: SCNTATCVTHRLAGLLSRSGGVVK DNFVPTNVGSEAF-NH2 3-Letter Code: Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 Molecular ...
发表评论
阅读全文